• Latest Posts

ITM follows €255M investment round by opening new facility

How cancer cells repair DNA damage from radiotherapy

New drug could replace current standard for treating brain cancer 

Actinium Pharmaceuticals and Columbia University to study Actimab-A in AML patients

Startup Graegis developing therapies for radiation side-effects

New radiopharmaceutical shrinks prostate cancer tumors


Study data for glioblastoma treatment confirms safety and tolerability profile